Cerebral small vessel disease and Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Cerebral small vessel disease (CSVD) is a group of pathological processes with multifarious etiology and pathogenesis that are involved into the small arteries, arterioles, venules, and capillaries of the brain. CSVD mainly contains lacunar infarct or lacunar stroke, leukoaraiosis, Binswanger's disease, and cerebral microbleeds. CSVD is an important cerebral microvascular pathogenesis as it is the cause of 20% of strokes worldwide and the most common cause of cognitive impairment and dementia, including vascular dementia and Alzheimer's disease (AD). It has been well identified that CSVD contributes to the occurrence of AD. It seems that the treatment and prevention for cerebrovascular diseases with statins have such a role in the same function for AD. So far, there is no strong evidence-based medicine to support the idea, although increasing basic studies supported the fact that the treatment and prevention for cerebrovascular diseases will benefit AD. Furthermore, there is still lack of evidence in clinical application involved in specific drugs to benefit both AD and CSVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Review: Cerebral microvascular pathology in ageing and neurodegeneration
Brown, W. R., & Thore, C. R. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01139.x · Cited by 749 · cited 1×
“CSVD precedes or accompanies cognitive dysfunction and neurodegeneration.(26) Several investigations indicate that”
The overlap between vascular disease and Alzheimer’s disease - lessons from pathology
Attems, J., & Jellinger, K. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0206-2 · Cited by 739 · cited 1×
“relationship between AD and cognitive impairment and VaD has been reported while CVD and stroke are related to high risk of both cognitive impairment and AD.(139,140) The manifestation of CVD in imaging is extremely similar to AD in the elderly, whereas imaging markers of subcortical vascular diseases (leukoaraiosis,…”
The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
Iadecola, C. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0718-6 · Cited by 557
Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy
Gurol, M. E., Irizarry, M. C., Smith, E. E., Raju, S., Diaz-Arrastia, R., Bottiglieri, T., Rosand, J., Growdon, J. H., & Greenberg, S. M. (2006) · Neurology · doi:10.1212/01.wnl.0000191403.95453.6a · Cited by 339
Brain microbleeds and Alzheimer’s disease: innocent observation or key player?
Cordonnier, C., & van der Flier, W. M. (2011) · Brain · doi:10.1093/brain/awq321 · Cited by 310 · cited 1×
“78,79 Cerebral microbleeds did not affect disease course in terms of progression to AD.”
PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis
Lockhart, A., Lamb, J. R., Osredkar, T., Sue, L. I., Joyce, J. N., Ye, L., Libri, V., Leppert, D., & Beach, T. G. (2007) · Brain · doi:10.1093/brain/awm191 · Cited by 302
Goos, J. D. C., Kester, M. I., Barkhof, F., Klein, M., Blankenstein, M. A., Scheltens, P., & van der Flier, W. M. (2009) · Stroke · doi:10.1161/strokeaha.109.558197 · Cited by 213 · cited 1×
“58 Multiple cerebral microbleeds have been shown to occur in AD and are linked with cerebral network breakdowns in the patients with AD, 59 affecting approximately one-third of subjects who are present with the clinical manifestations of AD dementia.”
Nonhypertensive Cerebral Small-Vessel Disease: An Autopsy Study
Lammie, G. A., Brannan, F., Slattery, J., & Warlow, C. (1997) · Stroke · doi:10.1161/01.str.28.11.2222 · Cited by 212 · cited 1×
“12 Despite atherosclerotic plaque biology has not been considered into being suitable to small cerebral vessels, a lesion by fibrinoid necrosis causing lacunar infarcts and primary intracerebral bleeds has been identified as an important pathology in the CSVD. 18 CSVD is a common aging phenomenon…”
Kester, M. I., Goos, J. D. C., Teunissen, C. E., Benedictus, M. R., Bouwman, F. H., Wattjes, M. P., Barkhof, F., Scheltens, P., & van der Flier, W. M. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.754 · Cited by 161 · cited 1×
“A crosssectional study showed that the presence of lacunar infarct was associated with higher Aβ42 in VaD and lower tau in AD in cerebrospinal fluid (CSF).(49) Another cross-sectional study demonstrated that the presence of lacunar infarctions could be tightly coupled to increased plasma Aβ40 and plasma Aβ40 concentra…”
Incidence of cerebral microbleeds in preclinical Alzheimer disease
Yates, P. A., Desmond, P. M., Phal, P. M., Steward, C., Szoeke, C., Salvado, O., Ellis, K. A., Martins, R. N., Masters, C. L., Ames, D., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000285 · Cited by 150 · cited 1×
“Concomitantly, older age, higher Aβ burden, and CVD may all facilitate the occurrence of lobar microbleeds.(66) A crosssectional study, investigating the prevalence, locations, and risk factors for cerebral microbleeds in neurodegenerative disorders identified that cerebral microbleeds are linked with vascular burden…”
Brain Atrophy and Cerebral Small Vessel Disease: A Prospective Follow-Up Study
Nitkunan, A., Lanfranconi, S., Charlton, R. A., Barrick, T. R., & Markus, H. S. (2011) · Stroke · doi:10.1161/strokeaha.110.594267 · Cited by 135 · cited 1×
“A prospective follow-up research conducted by Nitkunan et al showed that brain volume is decreased in the patients with CSVD with respect to normal aging subjects, and this decrease was correlated with cognition decline during 1-year prospective follow-up.(116) The leukoaraiosis and disability study further proved tha…”
Shams, S., Martola, J., Granberg, T., Li, X., Shams, M., Fereshtehnejad, S. M., Cavallin, L., Aspelin, P., Kristoffersen-Wiberg, M., & Wahlund, L. O. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4176 · Cited by 132
Chen, W., Song, X., Zhang, Y., & Initiative, F. T. A. D. N. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2541 · Cited by 130 · cited 1×
“It is well accepted that white matter hyperintensities (WMH) in imaging are linked with aging and AD.(93)”
The Role of SORL1 in Alzheimer’s Disease
Yin, R.-H., Yu, J.-T., & Tan, L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8742-5 · Cited by 126 · cited 1×
“Emerging data suggest that SORL1 acts as a central regulating role of the trafficking and processing of amyloid precursor protein and interacts with ApoE and tau protein.(71) A recent”
Schmidt, H., Zeginigg, M., Wiltgen, M., Freudenberger, P., Petrovic, K., Cavalieri, M., Gider, P., Enzinger, C., Fornage, M., Debette, S., et al. (2011) · Brain · doi:10.1093/brain/awr252 · Cited by 112
Whole-brain atrophy rate in Alzheimer disease: Identifying fast progressors
Sluimer, J. D., Vrenken, H., Blankenstein, M. A., Fox, N. C., Scheltens, P., Barkhof, F., & van der Flier, W. M. (2008) · Neurology · doi:10.1212/01.wnl.0000311446.61861.e3 · Cited by 110
Heringa, S. M., on behalf of the Utrecht Vascular Cognitive Impairment (VCI) Study Group, Reijmer, Y. D., Leemans, A., Koek, H. L., Kappelle, L. J., & Biessels, G. J. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130542 · Cited by 100
High Prevalence of Cerebral Microbleeds at 7Tesla MRI in Patients with Early Alzheimer's Disease
Brundel, M., Heringa, S. M., de Bresser, J., Koek, H. L., Zwanenburg, J. J. M., Kappelle, L. J., Luijten, P. R., & Biessels, G. J. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120364 · Cited by 97
Aribisala, B. S., Valdés Hernández, M. C., Royle, N. A., Morris, Z., Muñoz Maniega, S., Bastin, M. E., Deary, I. J., & Wardlaw, J. M. (2013) · European Radiology · doi:10.1007/s00330-012-2677-x · Cited by 91
Increased Number of Microinfarcts in Alzheimer Disease at 7-T MR Imaging
van Rooden, S., Goos, J. D. C., van Opstal, A. M., Versluis, M. J., Webb, A. G., Blauw, G. J., van der Flier, W. M., Scheltens, P., Barkhof, F., van Buchem, M. A., et al. (2014) · Radiology · doi:10.1148/radiol.13130743 · Cited by 86 · cited 1×
“It has been found that AD is highly prevalent in the elderly and often coexists with multimicroinfarcts; the number of microinfarcts is roughly in proportion to the degree of cognitive impairment, and the presence of microinfarcts was intimately linked with AD rather than cerebral amyloid angiopathy.(48) Lacunar infar…”
Richard, E., Gouw, A. A., Scheltens, P., & van Gool, W. A. (2010) · Stroke · doi:10.1161/strokeaha.109.571281 · Cited by 82
Imaging of cerebrovascular pathology in animal models of Alzheimer's disease
Klohs, J., Rudin, M., Shimshek, D. R., & Beckmann, N. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00032 · Cited by 82
Makedonov, I., Black, S. E., & MacIntosh, B. J. (2013) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03785.x · Cited by 62
Microvascular Burden and Alzheimer-Type Lesions Across the Age Spectrum
Costanza, A., Xekardaki, A., Kövari, E., Gold, G., Bouras, C., & Giannakopoulos, P. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120835 · Cited by 36 · cited 1×
“129–131 Genetic predispositions and environmental exposures may promote the development of CSVD and interact with normal aging to impact cognitive function.”
Pattern of and Risk Factors for Brain Microbleeds in Neurodegenerative Dementia
Olazarán, J., Ramos, A., Boyano, I., Alfayate, E., Valentí, M., Rábano, A., & Álvarez-Linera, J. (2014) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317513517043 · Cited by 23
Cited by
Cuadrado-Godia, E., Dwivedi, P., Sharma, S., Ois Santiago, A., Roquer Gonzalez, J., Balcells, M., Laird, J., Turk, M., Suri, H. S., Nicolaides, A., et al. (2018) · Journal of Stroke · doi:10.5853/jos.2017.02922 · Cited by 286
Getting to the Heart of Alzheimer Disease
Tublin, J. M., Adelstein, J. M., del Monte, F., Combs, C. K., & Wold, L. E. (2019) · Circulation Research · doi:10.1161/circresaha.118.313563 · Cited by 188
Dysfunction of the blood–brain barrier in Alzheimer's disease: Evidence from human studies
Kurz, C., Walker, L., Rauchmann, B., & Perneczky, R. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12782 · Cited by 183
“basement membrane changes and results in BBB breakdown and collapse in vessel wall integrity.(118,119) In histopathology, HA can appear with vessel fibrosis, infiltrating foam cells, astrogliosis and hemosiderin laden macrophages (Figure 3).”
BackgroundAPOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia
Mirza, S. S., Saeed, U., Knight, J., Ramirez, J., Stuss, D. T., Keith, J., Nestor, S. M., Yu, D., Swardfager, W., Rogaeva, E., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008377 · Cited by 67
Etiology of type 2 diabetes and Alzheimer’s disease: Exploring the mitochondria
Silzer, T. K., & Phillips, N. R. (2018) · Mitochondrion · doi:10.1016/j.mito.2018.04.004 · Cited by 53
Metadata
- Authors
- Cai, Z., Wang, C., He, W., Tu, H., Tang, Z., Xiao, M., & Yan, L.-J.
- Venue
- Clinical Interventions in Aging
- Publisher
- Informa UK Limited
- Published
- 2015-10
- Volume
- 10
- Pages
- 1695
- ISSN
- 1176-9092 (ISSN-L)
- 1178-1998
- OpenAlex
- W1852856437
- Cited by
- 98
- References
- 25
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.